Fibrocell Science, Inc. Cash and securities
- Total cash · latest quarter (USD): Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities. Period ending 2019-09-30..
- Cash per share · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2019-09-30..
Cash and securities
Overview →Financial period ending 2019-09-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total cash · latest quarter (USD) | (m) | Cash and cash equivalents plus current marketable securities. Period ending 2019-09-30. Calculation unavailable: missing inputs remain (m). |
| Cash per share · latest quarter | (m) | Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2019-09-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash and equivalents | 6.77M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total cash | Cash per share | Cash and equivalents (USD) | Short-term securities (USD) | Quarter-end shares (shares) |
|---|---|---|---|---|---|
| 2019-09-30 | (m) | (m) | $6.77M | (m) | (m) |
| 2019-06-30 | (m) | (m) | $13.68M | (m) | (m) |
| 2019-03-31 | (m) | (m) | $11.32M | (m) | (m) |
| 2018-12-31 | (m) | (m) | $14.43M | (m) | (m) |
| 2018-09-30 | (m) | (m) | $16.11M | (m) | (m) |
| 2018-06-30 | (m) | (m) | $15.41M | (m) | (m) |
| 2018-03-31 | (m) | (m) | $12.20M | (m) | (m) |
| 2017-12-31 | (m) | (m) | $17.42M | (m) | (m) |
| 2017-09-30 | (m) | (m) | $11.91M | (m) | (m) |
| 2017-06-30 | (m) | (m) | $15.91M | (m) | (m) |
| 2017-03-31 | (m) | (m) | $20.56M | (m) | (m) |
| 2016-12-31 | (m) | (m) | $17.52M | (m) | (m) |
| 2016-09-30 | (m) | (m) | $21.28M | (m) | (m) |
| 2016-06-30 | (m) | (m) | $8.16M | (m) | (m) |
| 2016-03-31 | (m) | (m) | $13.10M | (m) | (m) |
| 2015-12-31 | (m) | (m) | $29.27M | (m) | (m) |
| 2015-09-30 | (m) | (m) | $36.93M | (m) | (m) |
| 2015-06-30 | (m) | (m) | $26.85M | (m) | (m) |
| 2015-03-31 | (m) | (m) | $33.30M | (m) | (m) |
| 2014-12-31 | (m) | (m) | $37.49M | (m) | (m) |
| 2014-09-30 | (m) | (m) | $44.22M | (m) | (m) |
| 2014-06-30 | (m) | (m) | $49.54M | (m) | (m) |
| 2014-03-31 | (m) | (m) | $54.00M | (m) | (m) |
| 2013-12-31 | (m) | (m) | $60.03M | (m) | (m) |
| 2013-09-30 | (m) | (m) | $16.88M | (m) | (m) |
| 2013-06-30 | (m) | (m) | $20.81M | (m) | (m) |
| 2013-03-31 | (m) | (m) | $26.19M | (m) | (m) |
| 2012-12-31 | (m) | (m) | $31.35M | (m) | (m) |
| 2012-09-30 | (m) | (m) | $118.00K | (m) | (m) |
| 2012-06-30 | (m) | (m) | $2.56M | (m) | (m) |
| 2012-03-31 | (m) | (m) | $4.18M | (m) | (m) |
| 2011-12-31 | (m) | (m) | $10.80M | (m) | (m) |
| 2011-09-30 | (m) | (m) | $14.84M | (m) | (m) |
| 2010-12-31 | (m) | (m) | $868.00K | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.